Cardiopulmonary Bypass

Cardiopulmonary bypass is the technique that temporarily takes over the work of the heart and lungs during cardiac surgery. Venous blood is drained into a machine that adds oxygen, removes carbon dioxide, and pumps the blood back into the arterial system, so the surgeon can stop and open the heart while the rest of the body continues to be perfused. It is the technology that made open-heart surgery possible.

Definition

Cardiopulmonary bypass is a form of extracorporeal circulation in which a machine oxygenates venous blood and returns it to the arterial circulation, mechanically substituting for the heart and lungs during cardiac surgery.

Scope

This topic covers the principle of extracorporeal circulation, the main components of the bypass circuit, the physiological changes it produces, and the systemic inflammatory response associated with it. It is an educational reference to a surgical-support technique and does not provide perfusion protocols or treatment guidance.

Core questions

• How does the bypass circuit substitute for the heart and lungs?
• What are the essential components of the extracorporeal circuit?
• What physiological consequences and risks does bypass introduce?
• Why does bypass trigger a systemic inflammatory response?

Key concepts

• Extracorporeal circulation
• Venous drainage and cannulation
• Oxygenator (gas exchange)
• Arterial pump and return
• Systemic anticoagulation (heparinization)
• Systemic inflammatory response
• Hemodilution and priming

Mechanisms

In cardiopulmonary bypass, cannulae in the right atrium or vena cavae drain deoxygenated venous blood by gravity or assisted suction into a reservoir. The blood passes through an oxygenator, which performs gas exchange across a membrane, adding oxygen and removing carbon dioxide, and through a heat exchanger that controls temperature. A pump then returns the oxygenated blood under pressure to the arterial system, usually via the ascending aorta. Because contact between blood and the artificial surfaces of the circuit activates coagulation, the patient is fully anticoagulated, typically with heparin. The same blood-surface contact, along with ischaemia-reperfusion and the non-pulsatile flow, activates complement and leukocytes and provokes a systemic inflammatory response that contributes to post-bypass physiology.

Clinical relevance

Cardiopulmonary bypass is used in most open-heart operations and shapes the perioperative physiology that clinicians must understand. This entry explains how the technique works and why it produces characteristic systemic effects; it is a reference description and not a basis for perfusion management or individual treatment decisions.

Evidence & guidelines

Knowledge of cardiopulmonary bypass derives from the historical engineering work of Gibbon and colleagues and from a large physiological literature, including reviews of the systemic inflammatory response it produces. Much of the contemporary evidence concerns refinements - circuit coatings, flow strategies, and anti-inflammatory measures - rather than the principle itself, which is well established.

History

Cardiopulmonary bypass was the achievement of John Gibbon, who, with his wife Mary, spent decades developing a mechanical heart-lung apparatus and in 1953 used it to perform the first successful open-heart operation, the closure of an atrial septal defect. Miller, Gibbon, and Gibbon's 1951 reports document the apparatus's development, and subsequent decades brought membrane oxygenators, improved pumps, and safer circuits that made bypass routine.

Debates

How much of post-bypass morbidity is driven by the systemic inflammatory response?

Contact of blood with the artificial circuit and ischaemia-reperfusion activate inflammatory pathways, and the extent to which this contributes to organ dysfunction - and whether anti-inflammatory strategies improve outcomes - remains an active question.

Key figures

• John H. Gibbon Jr.
• Mary Hopkinson Gibbon
• C. Walton Lillehei

Seminal works

• gibbon-1978
• miller-1951
• pastuszko-2004

Frequently asked questions

Is the patient's own heart and lung function used during cardiopulmonary bypass?

No. During bypass the heart-lung machine performs gas exchange and circulation, allowing the heart to be stopped and the lungs to be deflated while the body remains perfused.

Why must patients be anticoagulated for cardiopulmonary bypass?

Blood contacting the artificial surfaces of the circuit would otherwise clot, so full anticoagulation (commonly with heparin) is required to keep the blood flowing through the machine.